This is a study for people with chronic kidney disease and type 1 diabetes. In this study, we want to learn more about the effectiveness and safety of a kidney drug called finerenone compared to a placebo.
Thank you for your interest, but this study is not currently enrolling.
North Carolina (Statewide)
Klara Klein
Medicine-Endocrinology
Clinical or Medical
Interventional
Chronic Conditions
Diabetes
Kidneys and Liver
UNC or UNC Health employees
UNC Students (undergrad, grad, professional)
23-1775
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
